The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population

Pharmacogenetics

Volumn 8, Issue 4, 1998, Pages 315-323

  Kiyohara, Chikako ^a   Nakanishi, Yoichi ^b   Inutsuka, Satoru ^c   Takayama, Koichi ^b   Hara, Nobuyuku ^b   Motohiro, Akira ^c   Tanaka, Keitaro ^a   Kono, Suminori ^a   Hirohata, Tomio ^d  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c National Minami Chest Hospital   (Japan)

^d NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

AHH activity; CYP1A1 polymorphism; Lung cancer

Indexed keywords

3 METHYLCHOLANTHRENE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; JAPAN; LUNG CANCER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A1; ENZYME INDUCTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; SMOKING;

EID: 0031853744     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199808000-00005     Document Type: Article

References (42)

1. Alfred LJ, Wojdani A. Effects of 3-methylcholanthrene and benzanthracene on blastogenesis and aryl hydrocarbon hydroxylase induction in splenic lymphocytes from three inbred strains of mice. Int J Immunopharmacol 1983; 5:123-129.
2. Atlas SA, Vesell ES, Nebert DW. Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Cancer Res 1976; 36:4619-4630.
3. 1450 locus (CYP1) and description of two RFLPs detected with 3′-P1450 cDNA probe. Cytogenet Cell Genent 1987; 46:574-575.
4. Crofts F, Taiolo E, Trachman J, Cosma GN, Currie D, Tonioli P, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 12:2961-2963.
5. Guirgis HA, Lynch HT, Mate T, Haris RE, Well I. Aryl hydrocarbon hydroxylase inducibility in lymphocytes from lung cancer patients and normal controls. Oncology 1976; 33:105-109.
6. 1450 gene on chromosome 15. Nucleic Acids Res 1990; 18:3114.
7. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 1991; 110:407-411.
8. Hayashi S, Watanabe J, Nakachi K, Eguchi H, Gotoh O, Kawajiri K. Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 1994; 15:801-806.
9. 1450 gene sequence and correlation of mRNA with genetic differences in benzo(a)pyrene metabolism. Nucleic Acids Res 1985; 13:4503-4520.
10. 1-450 gene linked to the MPI locus on chromosome 15. Nucleic Acid Res 1986; 14:4376.
11. Jett JR, Moses HL, Branum EL, Taylor WT, Fontana RS. Benzo(a)pyrene metabolism and blast transformation in peripheral blood mononuclear cells from smoking and nonsmoking populations and lung cancer patients. Cancer 1978; 41:192-200.
12. Kärki NT, Pokela R, Nuutinen L, Pelkonen O. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls. Int J Cancer 1987; 39:565-570.
13. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N. Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS 1990; 263:131-133.
14. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 1993; 14:77-87.
15. Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C, Hayashi S. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 1995; 5:151-158.
16. Kellermann G, Shaw CR, Luyten-Kellermann M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Engl J Med 1973a; 289:934-937.
17. Kellermann G, Luyten-Kellermann M, Shaw CR. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am J Hum Genet 1973b; 25:327-331.
18. Kiyohara C, Mohri N, Hirohata T, Haraguchi K, Masuda Y. In vitro effect of methylsulfonyl polychlorinated biphenyls and 7,8-benzoflavone on aryl hydrocarbon hydroxylase activity in human lymphoblastoid cells. Pharmacol Toxicol 1990: 66:273-276
19. Kiyohara C, Hirohata T, Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene, Jpn J Cancer Res 1996; 87:18-24.
20. Kiyohara C, Hirohata T. Environmental factors on aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes. J Epidemiol 1997; 7:244-250.
21. Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 1982; 42:5030-5037.
22. Landers JP, Bunce NJ. The Ah receptor and the mechanism of dioxin toxicity. Biochem J 1991; 276:273-287.
23. Lieberman J. Aryl hydrocarbon hydroxylase in bronchogenic carcinoma. N Engl Med 1978; 298:686-687.
24. Nakachi K, Imai K, Hayashi S-I, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991; 51:5177-5180.
25. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993; 53:2994-2999.
26. Nebert DW, Benedict WF, Kouri RE. Aromatic hydrocarbon produced tumorigenesis and the genetic difference in aryl hydrocarbon hydroxylase. In: Ts'o POP, DiPaolo JA, editors. Chemical carcinogenesis. Part A. New York: Marcel Decker Inc: 1974, pp. 271-288.
27. Nebert DW, Jensen NM. The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. CRC Crit Rev Biochem 1979; 6:401-437.
28. Nebert DW. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol 1989; 20:153-174.
29. 1450 (CYP1A1) gene. Int J Biochem 1989; 21:234-252.
30. Paigen B, Minowada J, Gurtoo HL, Paigen K, Parker NB, Ward E, et al. Distribution of arylhydrocarbon hydroxylase inducibility in cultured human lymphocytes. Cancer Res 1977; 37:1829-1837.
31. Paigen B, Gurtoo HL, Minowada J, Ward E, Houten J, Paigen K, et al. Genetics of aryl hydrocarbon hydroxylase in the human population and its relationship to lung cancer. In: Gelboin HV, Ts'o POP, editors. Polycyclic hydrocarbons and cancer Vol. 2. New York: Academic Press: 1978. pp. 391-405.
32. Paigen B, Ward E, Reilly A, Houten L, Gurtoo HL, Minowada J, et al. Season variation of aryl hydrocarbon hydroxylase activity in human lymphocytes. Cancer Res 1981;41:2757-2761.
33. Persson I, Johansson I, Ingelman-Sundberg M. In-vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun 1997; 231:227-230.
34. Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 1991; 48:720-725.
35. Prasad R, Prasad S, Harrell JE, Thornby J, Liem JH, Hudgins PH, et al. Aryl hydrocarbon hydroxylase inducibility and lymphoblast formation in lung cancer patients. Int J Cancer 1979; 23: 316-320.
36. Raben M, Walach N, Galili U, Schlesinger M. The effect of radiation therapy on lymphocytes subpopulations in cancer patients. Cancer 1976; 37:3771-3773.
37. Richter A, Kadar D, Liszka-Hagmajer E, Kalow W. Seasonal variation of aryl hydrocarbon hydroxylase inducibility in human lymphocytes in culture. Res Comm Chem Pathol Pharmacol 1978; 19:453-475.
38. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA sequencing with a thermostable DNA polymerase. Science 1988; 239:487-491.
39. SAS Institute, Inc. SAS/STAT user's guide. Release 6.03. Cary, NC, USA: SAS Institute: 1988.
40. Spurr NK, Gough AC, Stevenson K, Wolf CR. MspI polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res 1987; 15:5901.
41. Trell E, Kordgaard R, Hood B, Kittzing O, Norden G, Simonsson BG. Aryl hydrocarbon hydroxylase inducibilily and laryngeal carcinomas [letter] Lancet 1976; 2:140.
42. Ward E, Paigen B, Steenland K, Vincent R, Minowada J, Gurtoo HL, et al. Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer. Int J Cancer 1978; 22:384-389.